Red cell affinity column technology
Red cell affinity column technology (ReACT) was a method for detecting any clinically important antibodies in patient serum.
≈ 2 min read
Names in other languages
No names in other languages are held for this entry yet.
Article bodies are English and are not machine-translated. A name in another language is not a translation of the article.
Red cell affinity column technology (ReACT) was a method for detecting any clinically important antibodies in patient serum. Whereas gel agglutination is based on size exclusion of agglutinated red cells in an inert matrix, red cell affinity column technology was based on affinity adherence of red cells in an immunologically active matrix.
In ReACT, antibody-sensitized red cells bind to ligands attached to an agarose matrix. The main ligand is Protein G (prepared from Group C or G Streptococcus or by recombinant technology), which has high affinity for all four IgG subclasses. Another ReACT ligand is Protein A (from Group A Staphylococcus), which binds to IgG 1, 2, and 4.
A study published in 20021 showed a loss of sensitivity for detecting significant antibodies. Unrelated to the study the ReACT kit was withdrawn from the market soon afterwards.
Text derived from https://en.wikipedia.org/w/index.php?oldid=1358217839 under CC BY-SA 4.0; modifications have been made.
References
- ↩Wikipedia “Red cell affinity column technology” publication date (×1) · confidence 0.95 revision URL